Title |
Japanese encephalitis: a review of clinical guidelines and vaccine availability in Asia
|
---|---|
Published in |
Tropical Diseases, Travel Medicine and Vaccines, November 2015
|
DOI | 10.1186/s40794-015-0013-6 |
Pubmed ID | |
Authors |
Patricia Batchelor, Kyle Petersen |
Abstract |
Travelers to Asia are at risk for acquiring Japanese Encephalitis (JEV), an arbovirus with high rates of morbidity and mortality. Recent advances in vaccination resulting in vaccines with low rates of side effects have strengthened the rationale to vaccinate more travelers to this region, as reflected in many updated national guidelines for prevention of disease in travelers. Vaccines however still require a complex pre-travel schedule and are costly, often leading to a requirement or desire for a vaccination option in the destination country. We explore current national guidelines for prevention of Japanese Encephalitis and seek to provide information on availability of JEV vaccines in various Asian countries. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 1% |
Unknown | 66 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 11 | 16% |
Student > Master | 11 | 16% |
Other | 8 | 12% |
Student > Ph. D. Student | 5 | 7% |
Researcher | 5 | 7% |
Other | 13 | 19% |
Unknown | 14 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 25 | 37% |
Immunology and Microbiology | 5 | 7% |
Biochemistry, Genetics and Molecular Biology | 4 | 6% |
Nursing and Health Professions | 4 | 6% |
Agricultural and Biological Sciences | 3 | 4% |
Other | 10 | 15% |
Unknown | 16 | 24% |